MedPath

Mobile Smoking Treatment for Hispanic Individuals Who Smoke

Not Applicable
Not yet recruiting
Conditions
Smoking Cessation
Interventions
Behavioral: Impacto (Mobile App)
Registration Number
NCT06586034
Lead Sponsor
University of Houston
Brief Summary

The specific aims of the project are to develop and test a mobile application for smoking cessation for Hispanic individuals who smoke called Impacto.

Detailed Description

A total of 56 Hispanic individuals who smoke will be recruited for this project. Six (6) participants will complete usability/functionality testing of Impacto 2.0 in the English language for both iOS and Android. Following usability/functionality testing, a field test with 50 adult Hispanic individuals who smoke (50% English-speaking and 50% Spanish-speaking) will be recruited nationally and will receive Impacto 2.0 (50% Android and iOS platforms).

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
56
Inclusion Criteria
    1. being Hispanic, 2) at least 18 years of age, 2) currently smoking (i.e., at least 5 cigarettes/day) biochemically verified by a CO > 7, 3), meeting criteria for high AS (cut-off score of 5 on the Short Scale Anxiety Sensitivity Index), 4) motivation to quit > 5 on a 10 pt. scale, 5) able to provide informed consent, 6) has daily access to their own iPhone or Android smartphone, and 7) is a fluent English or Spanish speaker.
Exclusion Criteria
    1. current participation in substance abuse treatment, 2) in psychotherapy for anxiety or depression, 3) concurrent use of medication for anxiety or depression, 4) active suicidality (ideation, intent, and/or plan), or 5) current psychosis.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ImpactoImpacto (Mobile App)This is the mobile application to be developed and evaluated in this project.
Primary Outcome Measures
NameTimeMethod
7-Day Point Prevalence Smoking AbstinenceEnd of treatment (Week 8)

7-day point prevalence smoking status (verification via carbon monoxide).

Secondary Outcome Measures
NameTimeMethod
Anxiety SensitivityBaseline, week 4, and end of treatment (Week 8)

Anxiety sensitivity will be assessed using the Short Scale Anxiety Sensitivity Index (SSASI).

© Copyright 2025. All Rights Reserved by MedPath